in Bar Harbor, Maine, has announced a grant of more than $8.4 million from the in support of its efforts to enhance cancer diagnostics and treatment in the state.
Founded in 1929 as one of the world's first cancer genetics research institutions, JAX has recently expanded its efforts to include translational and clinical genomics research and advanced genomics diagnostics tools for oncologists and their patients. A spokesperson for the organization told the that it is "working in close collaboration with the Maine-based oncologist community regarding the optimal approach for achieving our shared goal to advance cancer diagnostics and treatment in Maine."
"Most American cancer patients get their care at community hospitals, in rural or suburban settings, and this is especially true in Maine," said Edison Liu, president and CEO of the lab and director of the Jackson Laboratory Cancer Center. "Thanks to the vision of the Harold Alfond Foundation and, working in collaboration with MaineGeneral Medical Center and its Harold Alfond Center for Cancer Care, JAX will work to ensure that all Maine cancer patients and their physicians have access to precision cancer care using the latest advances in genetic technologies, allowing them to determine the best treatment for a particular cancer."